The top analyst upgrades, downgrades and initiations seen on Thursday included Alcoa, Cars.com, CVS Health, Electronic Arts, Halliburton, PNC Financial Services, Salesforce.com, Walgreens Boots Alliance and UnitedHealth.
CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.
Drugmaker Tris Pharma has recalled a baby ibuprofen medication sold at Walmart, CVS, and Family Dollar stores under house brand names.
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
CVS is scheduled to release its second-quarter financial results before the markets open on Wednesday.
Chris Lange 24/7 Wall St. has put together a preview of Disney, Snap, CVS Health and some of the other companies that are about to report their quarterly results.
The top analyst upgrades, downgrades and other research calls from Monday include Baidu, Capital One, Delphi Technologies, Dunkin' Brands, FireEye and Walgreens Boots Alliance.
Stocks were looking for a higher open on Tuesday, with this day being a shortened one ahead of the July 4th holiday. The prior trend of buying the dips has not worked…
Amazon's announced acquisition of pharmacy firm PillPack has sent a shockwave through retail pharmacy stocks, pharmacy benefits management companies, and drug distribution firms. And the deal isn't even closed yet.
GE is dropped from the Dow Jones industrial average, Volkswagen and Ford may build new cars together, and other important headlines.
Tuesday was another down day for the broad U.S. markets, with all major exchanges taking a step back. Crude oil recovered backed off again and is hovering just above $65. The S&P…
CVS Health and Aetna are closing in on finalizing the acquisition, and the companies have now announced the management team going forward.
24/7 Wall St. has put together a preview of Alibaba, CVS, Tesla and some of the other most anticipated earnings reports due in the coming week.
The top analyst upgrades, downgrades and other research calls from Monday include Alcoa, CEMEX, Comerica, Facebook, General Motors, Incyte, Proofpoint and Regeneron Pharmaceuticals.
Eldorado Gold, CVS Health, Kimco Realty, and Finisar all posted new 52-week lows Tuesday.
